Successfully, we identified the most significant (p value ≤9.14 × 10−09) four associated SNPs [SNRK and SNRK-AS1-rs202018563G; BRCA2-rs2227943C; ZNF484-rs199826847C; and DCPS-rs1695739G] among persons with breast cancer versus the healthy controls even after Bonferroni corrections (p value <2.05 × 10−07). This evidence concerns the gene BRCA2 and breast carcinoma.